In Brief: Penile rigidity implant downclassification
This article was originally published in The Gray Sheet
Executive Summary
Penile rigidity implant downclassification: FDA publishes proposed rule in Dec. 16 Federal Register to downclassify the preamendment Class III devices to Class II. Comments are due by March 16. A December 1996 510(k) guidance document, a revised draft of which was released by FDA in January, would serve as a special control ("The Gray Sheet" Feb. 3, p. 12). FDA is proposing the downclassification based on data it received from the Health Industry Manufacturers Association and Mentor Corp. under a Sec. 515(i) order calling for safety and effectiveness data...
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.